MGLN Magellan Health Inc

Price (delayed)

$93.32

Market cap

$2.42B

P/E Ratio

6.16

Dividend/share

N/A

EPS

$15.14

Enterprise value

$1.92B

Sector: Healthcare
Industry: Healthcare Plans

Highlights

Magellan Health's quick ratio has soared by 199% from the previous quarter and by 181% YoY
The net income has soared by 185% QoQ
Magellan Health's gross profit has decreased by 40% QoQ and by 26% YoY
Magellan Health's gross margin has decreased by 32% from the previous quarter and by 26% YoY

Key stats

What are the main financial stats of MGLN
Market
Shares outstanding
25.97M
Market cap
$2.42B
Enterprise value
$1.92B
Valuations
Price to earnings (P/E)
6.16
Price to book (P/B)
1.28
Price to sales (P/S)
0.52
EV/EBIT
5.2
EV/EBITDA
3.93
EV/Sales
0.42
Earnings
Revenue
$4.58B
EBIT
$368.67M
EBITDA
$487.41M
Free cash flow
$375.28M
Per share
EPS
$15.14
Free cash flow per share
$14.66
Book value per share
$73.03
Revenue per share
$178.76
TBVPS
$93.97
Balance sheet
Total assets
$3.36B
Total liabilities
$1.46B
Debt
$638.38M
Equity
$1.87B
Working capital
$1.42B
Liquidity
Debt to equity
0.34
Current ratio
2.92
Quick ratio
2.75
Net debt/EBITDA
-1.04
Margins
EBITDA margin
10.6%
Gross margin
2.6%
Net margin
8.4%
Operating margin
-0.3%
Efficiency
Return on assets
11.5%
Return on equity
23.8%
Return on invested capital
23.1%
Return on capital employed
14.1%
Return on sales
8.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MGLN stock price

How has the Magellan Health stock price performed over time
Intraday
0.13%
1 week
0.09%
1 month
-1.3%
1 year
39.01%
YTD
12.65%
QTD
12.65%

Financial performance

How have Magellan Health's revenue and profit performed over time
Revenue
$4.58B
Gross profit
$118.79M
Operating income
-$13.67M
Net income
$382.34M
Gross margin
2.6%
Net margin
8.4%
The net income has soared by 185% QoQ
Magellan Health's operating margin has plunged by 127% YoY and by 123% from the previous quarter
Magellan Health's operating income has shrunk by 127% YoY and by 120% QoQ
Magellan Health's gross profit has decreased by 40% QoQ and by 26% YoY

Growth

What is Magellan Health's growth rate over time

Valuation

What is Magellan Health stock price valuation
P/E
6.16
P/B
1.28
P/S
0.52
EV/EBIT
5.2
EV/EBITDA
3.93
EV/Sales
0.42
MGLN's EPS has soared by 181% since the previous quarter
The stock's price to earnings (P/E) is 86% less than its 5-year quarterly average of 43.4 and 49% less than its last 4 quarters average of 12.0
MGLN's equity is up by 34% year-on-year and by 18% since the previous quarter
The P/B is 16% more than the last 4 quarters average of 1.1 but 9% less than the 5-year quarterly average of 1.4
MGLN's price to sales (P/S) is 30% higher than its 5-year quarterly average of 0.4 and 30% higher than its last 4 quarters average of 0.4
The revenue has declined by 12% since the previous quarter

Efficiency

How efficient is Magellan Health business performance
MGLN's ROA has soared by 180% since the previous quarter
MGLN's ROS has soared by 179% since the previous quarter
MGLN's return on invested capital has surged by 172% since the previous quarter
The company's return on equity has surged by 164% QoQ

Dividends

What is MGLN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MGLN.

Financial health

How did Magellan Health financials performed over time
The total assets is 131% more than the total liabilities
Magellan Health's quick ratio has soared by 199% from the previous quarter and by 181% YoY
Magellan Health's current ratio has soared by 59% YoY and by 40% from the previous quarter
Magellan Health's debt is 66% lower than its equity
MGLN's equity is up by 34% year-on-year and by 18% since the previous quarter
MGLN's debt to equity is down by 31% YoY and by 17% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.